LMU Biocenter, main lecture hall, B00.019
In 1999 the German Research Council installed an Ombudsman to safeguard research integrity nationwide. In this presentation the current personal composition, the catalogue of tasks and the challenge of handling conflict situations of this body will be discussed. The integration of the German Ombudsman into the international network of comparable institutions will be briefly outlined.
In many areas of biomedicine bench-to-bedside translation has a bad track record, and despite tremendous advances of understanding disease mechanisms in animal models disappointingly few of these findings lead to more effective treatments for patients and better outcomes. Ulrich Dirnagl will expose how quality problems in basic and preclinical experimental research may contribute to this 'translational roadblock'. A particular focus will be on factors that are under the control of the experimenter (i.e. you!), such as measures to reduce bias and improve internal and external validity.
Science depends on communication of scientific findings and traditionally this has been a measure of achievement and as such used in the assessment of career progression. Over the last few years, the journals we used to publicize our findings in, have been playing a more influential role in the evaluation of the results. Nowadays, it is where you publish, rather than what you publish, that often determines how the work is perceived. This has led to deterioration in the way we do science and, more importantly, a challenge in the way PhDs are conceived and performed. Issues of the method of peer review, the ownership of the publication and the impact that these shifts in focus have on career progression are very much at the center of science discussions today. I shall be considering these issues and possible solutions to the gridlock in which we find ourselves.